title: [MSD executive calls for more transparency and expertise. 9 out of 10 innovations fail due to a too brief value assessment (interview by Wolfgang van den Bergh, Dirk Einecke and Cornelius Heyer)].
authors.forename: Hanspeter
authors.initials: H
authors.lastname: Quodt
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D004059:Diffusion of Innovation; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005858:Germany; D006801:Humans; D009313:National Health Programs / Q000331:legislation & jurisprudence* / Q000639:trends*